BASKING RIDGE, NJ--(Marketwired - Jan 26, 2016) - TurnPoint Medical Devices, Inc., a provider of innovative medical device solutions, today announced three new appointees to their Board of Directors -- and additional senior leadership and experience to their already talented and industry-expert management team.

David L. Bonderud is currently an Operating Partner with Chicago Private Equity firms focused in the healthcare space, bringing a wealth of healthcare and medical device experience to TurnPoint. He has held various roles in a 31 year career with Baxter Healthcare Corporation, including leading its $1.8 billion US Hospital Products business for 9 years, with responsibility for IV pump, IV solution, Nutrition therapy and Pharmacy product portfolios. With a focus on IV products, he has also held senior management roles with global Baxter business units leading teams developing, marketing and selling innovative solutions for patients and the care providers that deliver their therapies.

R. Douglas Hulse is an Executive Director and Principal at The Sage Group, a leading international consultancy in the field of Pharma, biotech and medical devices. He has to his credit several entrepreneurial businesses he founded, including I-stat, the diagnostic firm that was sold to Abbott Labs for nearly $400 million;

Christopher J. York is one of the most successful entrepreneurs in the Specialty/Home Infusion market. During his 27 year career he has held senior leadership positions in large national companies and has built and consolidated three market-leading Specialty Infusion providers. Most recently, he built SCP Specialty Infusion, which was acquired by Axelacare Health Solutions, a large nationwide provider of infusion services. Subsequently, Mr. York has served on the Board of Directors of Axelacare.

"We are delighted to have attracted such individuals to our Board that have senior management experience in medical businesses directly relevant to our commercial strategy. We plan to launch our new large volume infusion pump into the fast growing home infusion and cancer clinic infusion market in the 3rd quarter this year," said Mr. John Toedtman, Chairman and CEO of TurnPoint Medical Devices.

"In addition, we reached another milestone for our IP, namely the US Patent Office has allowed the claims on two U.S. patents, one for the revolutionary pneumatic-assist direct drive IV pump system including novel 'positive air elimination', and a companion patent that is the disposable device that achieves 'positive air elimination'," he concluded.

About TurnPoint Medical Devices, Inc.
TurnPoint Medical Devices Inc. identifies and rapidly commercializes medical devices that employ the latest medical technology. We employ a straightforward business strategy to identify, develop and deliver impactful, state-of-the-art products and services that safely provide improved outcomes for patients and healthcare providers. For more information about TurnPoint's offerings, contact us at or visit our website at

Contact Information:

Contact info:
Harriet L. Donnelly
e5 Marketing Inc.
908-901-9280 (office)
908-392-3801 (cell)